Chlorhexidine EP Impurity N
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

152504-10-4Chlorhexidine EP Impurity N

● In Stock

Catalogue No.:VE009301
CAS No.:152504-10-4
Mol. Formula:C15H25ClN8
Mol. Weight:352.87 g/mol

Additional information on CAS 152504-10-4

Parent drug

Chlorhexidine

IUPAC Name

1-[6-(Carbamimidoylamino)hexyl]-5-(4-chlorophenyl)biguanide

Synonyms

Chlorhexidine guanidine

Description

Chlorhexidine EP Impurity N, also termed chlorhexidine guanidine, is a basic diguanide-related process impurity associated with chlorhexidine manufacturing or oxidative and hydrolytic transformation of the biguanide framework. CAS 152504-10-4; molecular formula C15H25ClN8; molecular weight 352.87 g/mol. The structure retains the cationic chlorophenyl biguanide motif, supporting strong ionization and chromatographic tailing on conventional reversed-phase systems. Quantification generally requires LC-MS/MS or LC-HRMS, with occasional ion-pair LC or HILIC optimization and confirmatory NMR for structural assignment. As a specified pharmacopoeial impurity, it is evaluated within impurity profiling and impurity qualification frameworks rather than as a simple degradation marker.

References

Lim, K. -S ., and P. C. A. Kam. “Chlorhexidine – Pharmacology and Clinical Applications.” Anaesthesia and Intensive Care, vol. 36, no. 4, July 2008, pp. 502–12, https://doi.org/10.1177/0310057×0803600404. ‌

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url